Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD

Y. Suzuki (Fukushima, Japan), J. Saito (Fukushima, Japan), M. Rikimaru (Fukushima, Japan), M. Uematsu (Fukushima, Japan), A. Fukuhara (Fukushima, Japan), S. Sato (Fukushima, Japan), T. Kawamata (Fukushima, Japan), . Togawa (Fukushima, Japan), . Sato (Fukushima, Japan), T. Nikaido (Fukushima, Japan), N. Fukuhara (Fukushima, Japan), Y. Tanino (Fukushima, Japan), Y. Shibata (Fukushima, Japan)

Source: International Congress 2019 – Evaluation of basic science in airway diseases
Session: Evaluation of basic science in airway diseases
Session type: Poster Discussion
Number: 1707

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Suzuki (Fukushima, Japan), J. Saito (Fukushima, Japan), M. Rikimaru (Fukushima, Japan), M. Uematsu (Fukushima, Japan), A. Fukuhara (Fukushima, Japan), S. Sato (Fukushima, Japan), T. Kawamata (Fukushima, Japan), . Togawa (Fukushima, Japan), . Sato (Fukushima, Japan), T. Nikaido (Fukushima, Japan), N. Fukuhara (Fukushima, Japan), Y. Tanino (Fukushima, Japan), Y. Shibata (Fukushima, Japan). Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD. 1707

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: